Latest Bristol-Myers Squibb Stories
NEW YORK, March 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company") (NASDAQ: MDCO) and certain of its officers.
BUFFALO, N.Y., March 19, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral
DOYLESTOWN, Pa., March 19, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., today announced that Christian S.
Rapid CYP2C19 Testing for Personalized Antiplatelet Therapy in 600-Patient Clinical Trial with Spartan Bioscience (PRWEB) March 18, 2014 Spartan Bioscience
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
SAN DIEGO, March 17, 2014 /PRNewswire/ -- Cardium Therapeutics Inc.
CALGARY, March 13, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
LAS VEGAS, March 6, 2014 /PRNewswire/ - Vansen Pharma Inc. [OTCQB: VNSN] is pleased to announce the appointment of Mr.
SAN DIEGO, March 6, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO and PARSIPPANY, N.J., March 3, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.